| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.4M | +459.3% |
| Cost of Revenue | $8.2M | +25.7% |
| Gross Profit | -$2.8M | +49.7% |
| R&D Expense | $7.0M | -30.4% |
| SG&A Expense | $18.3M | -50.8% |
| Operating Income | -$29.2M | +46.4% |
| Pre-tax Income | -$34.9M | +32.0% |
| Income Tax | $0 | — |
| Net Income | -$34.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $138K | — |
| Accounts Receivable | $1.4M | — |
| Inventory | $6.7M | +21.3% |
| Current Assets | $8.2M | +53.4% |
| Total Assets | $34.2M | +103.4% |
| Current Liabilities | $26.9M | +24.8% |
| Long-term Debt | $11.3M | +14.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.8M | +4.0% |
| Investing Cash Flow | -$1.7M | -17.9% |
| Financing Cash Flow | $16.3M | -4.5% |
| +32.0% |
| EPS (Basic) | -$163.28 | -3834.5% |
| EPS (Diluted) | -$163.28 | -3834.5% |
| Total Liabilities |
| $27.1M |
| +21.0% |
| Stockholders' Equity | $7.1M | +228.2% |